Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

JPMorgan Multi-Cap Market Neutral Fund Select Class (OGNIX)

Net Asset Value
1 Day
Overall Morningstar Rating
Market neutral
Style or Category
No Load
Sales Expenses
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital preservation and growth by using strategies designed to produce returns which have no correlation with general domestic market performance. The fund attempts to neutralize exposure to general domestic market risk by primarily investing in common stocks that the fund's adviser considers to be attractive and 'short selling' stocks that the adviser considers to be unattractive. It uses a multi-style approach, meaning that it may invest across different industries, sectors and capitalization levels targeting both value-and growth-oriented domestic companies.


1 month0.00% 3 years+1.31%
3 months+0.30% 5 years+0.72%
1 year+0.20% Since inception+1.45%
Data through --

Peer Comparisonvs. Market neutral

Performance 5-yr return+0.72%+1.49%
Expense ratio2.51%1.72%
Risk 5 year sharpe ratio0.350.16
Net assets$271.8M$481.7M
Average market cap$10.9B$34.6B
Average P/E17.718.3
Portfolio turnover204%204%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyJPMorgan
Fund manager & tenureDennis Ruhl / 2 Years
Minimal initial investment$1,000,000.00
Minimum IRA investment--


U.S. stock2.06%
International stock0.00%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Consumer goods 14.76%
Industrial materials 14.17%
Financial service 12.46%
Healthcare 11.42%
Consumer service 10.70%
Top 10 Holdings
Portfolio weighting
EL Estee Lauder1.22%
JKHY Jack Henry & Associates Inc1.18%
ULTI Ultimate Software Group Inc1.18%
P Pandora Media Inc1.16%
DOX Amdocs Ltd1.12%
VRSN Verisign Inc1.11%
BFB Brown-Forman Corp1.10%
MKC McCormick & Company Inc1.09%
PFE Pfizer1.09%
TGT Target1.09%

Partner Offers